|
SNTB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.42440000000666E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.159100E-03 |
| Normal-vs-Stage2 |
6.195800E-04 |
| Normal-vs-Stage3 |
1.51749999999229E-05 |
| Normal-vs-Stage4 |
3.93610000004596E-06 |
| Stage1-vs-Stage2 |
1.413780E-01 |
| Stage1-vs-Stage3 |
1.515840E-02 |
| Stage1-vs-Stage4 |
1.251670E-02 |
| Stage2-vs-Stage3 |
7.582000E-01 |
| Stage2-vs-Stage4 |
6.905000E-01 |
| Stage3-vs-Stage4 |
9.117000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.16709999999854E-05 |
| Normal-vs-AfricanAmerican |
7.223400E-03 |
| Normal-vs-Asian |
8.112800E-01 |
| Caucasian-vs-AfricanAmerican |
8.666000E-01 |
| Caucasian-vs-Asian |
9.964300E-02 |
| AfricanAmerican-vs-Asian |
1.805760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.0449000000038E-05 |
| Normal-vs-Female |
7.819000E-04 |
| Male-vs-Female |
4.404600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.052250E-02 |
| Normal-vs-Age(41-60Yrs) |
2.221400E-03 |
| Normal-vs-Age(61-80Yrs) |
3.68049999999176E-06 |
| Normal-vs-Age(81-100Yrs) |
2.756400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.636200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.656200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.786200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.696100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.556400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.969800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.109400E-01 |
| Normal-vs-Grade 2 |
6.442800E-03 |
| Normal-vs-Grade 3 |
7.62409999577329E-08 |
| Normal-vs-Grade 4 |
4.91079999997979E-06 |
| Grade 1-vs-Grade 2 |
6.350400E-02 |
| Grade 1-vs-Grade 3 |
2.007800E-02 |
| Grade 1-vs-Grade 4 |
1.676710E-03 |
| Grade 2-vs-Grade 3 |
5.499300E-03 |
| Grade 2-vs-Grade 4 |
1.231970E-02 |
| Grade 3-vs-Grade 4 |
5.582600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.560500E-03 |
| Normal-vs-ccB subtype |
3.951400E-04 |
| ccA subtype-vs-ccB subtype |
1.259000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.435600E-04 |
| Normal-vs-N1 |
4.444400E-03 |
| N0-vs-N1 |
3.856800E-01 |
|
|
